Page last updated: 2024-09-03

gefitinib and phosphothreonine

gefitinib has been researched along with phosphothreonine in 1 studies

Compound Research Comparison

Studies
(gefitinib)
Trials
(gefitinib)
Recent Studies (post-2010)
(gefitinib)
Studies
(phosphothreonine)
Trials
(phosphothreonine)
Recent Studies (post-2010) (phosphothreonine)
5,2315662,9191,2170249

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Hoque, A; Li, J; Liu, Z; Oakhill, J; Proud, CG; Qi, X; Wang, G; Wang, X; Wang, Y; Wu, Y; Xiao, M; Xie, J1

Other Studies

1 other study(ies) available for gefitinib and phosphothreonine

ArticleYear
The eEF2 kinase-induced STAT3 inactivation inhibits lung cancer cell proliferation by phosphorylation of PKM2.
    Cell communication and signaling : CCS, 2020, 02-13, Volume: 18, Issue:1

    Topics: Animals; Carrier Proteins; Cell Line, Tumor; Cell Proliferation; Elongation Factor 2 Kinase; Gefitinib; HEK293 Cells; Humans; Lung Neoplasms; Membrane Proteins; Mice, Nude; Phosphorylation; Phosphothreonine; Protein Multimerization; Proto-Oncogene Proteins c-myc; STAT3 Transcription Factor; Thyroid Hormone-Binding Proteins; Thyroid Hormones; Tumor Burden

2020